Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001697573 | SCV000719430 | likely benign | not provided | 2020-12-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000634692 | SCV000756026 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000634692 | SCV002554657 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270774 | SCV002554660 | benign | Fibromuscular dysplasia, multifocal | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341566 | SCV002635014 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-11-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003323632 | SCV004029992 | benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001697573 | SCV005877524 | benign | not provided | 2024-05-21 | criteria provided, single submitter | clinical testing |